Objective To analyze the clinical characteristics and risk factors of extreme thrombocytosis caused by piperacillin sodium and tazobactam sodium injection, and provide reference for medical treatment and pharmaceutical care of such patients. Methods Extreme thrombocytosis of a patient treated with piperacillin sodium and tazobactam sodium injection was found by clinical pharmacists, who participated in clinical diagnosis and treatment by analyzing of the adverse drug reaction, optimization of the medical treatment and pharmaceutical care. Results After correlation analysis, the patient's extreme thrombocytosis was likely to be an adverse reaction caused by the piperacillin sodium and tazobactam sodium injection. The medication was immediately discontinued, and antiplatelet therapy with aspirin was administered. Two weeks later, the patient's platelet count had significantly decreased compared to before. Conclusion Clinical pharmacists participated in patients’ clinical diagnosis and treatment, carried out pharmaceutical care and assisted physicians in adjusting treatment plans, which ensured the safety and effectiveness of patients' clinical drug therapy.

Mass spectrometry imaging （MSI） is an emerging molecular imaging technique that combines high spatial resolution and the ability to acquire molecular information. This technology can directly obtain spatial distribution maps of metabolites, proteins, lipids and other molecules in tumor tissues, reveal the abnormal molecular changes during the occurrence and development of liver cancer, and make up for the deficiency of information at the molecular level in traditional imaging （such as CT, MRI）. In liver cancer research, MSI has demonstrated unique advantages and application potential in early diagnosis and screening, precise classification, tumor heterogeneity analysis, and exploration of molecular mechanisms. The principle characteristics of MSI technology and its latest progress in the early diagnosis, classification and molecular mechanism research of liver cancer were reviewed, and the current challenges and future development directions were discussed, which aimed to provide a new perspective and theoretical basis for an in-depth understanding of the pathological mechanism of liver cancer and promoted its precise diagnosis and treatment.

OBJECTIVE To evaluate the efficacy and safety of cadonilimab plus chemotherapy in patients with advanced gastric adenocarcinoma or adenocarcinoma of gastroesophageal junction （AEG） with intermediate， low， or no human epidermal growth factor receptor 2 （HER2） expression. METHODS Patients with advanced gastric adenocarcinoma or AEG with intermediate， low， or no HER2 expression who were treated at Liaoning Cancer Hospital between October 1， 2024 and June 30， 2025 were retrospectively included. According to the treatment regimen received， the patients were divided into group A [cadonilimab plus oxaliplatin and capecitabine （XELOX）， n ＝54 ] ， group B （sintilimab plus XELOX， n ＝68）， and group C （tislelizumab plus XELOX， n ＝49）. Short-term efficacy after 4 cycles of treatment， survival outcomes， and adverse events were compared among the three groups. Cox regression and Logistic regression analyses were further performed to evaluate the effects of the treatment regimen and baseline data on survival outcomes and the risk of grade 3-4 treatment related adverse events （TRAEs）. RESULTS No statistically significant differences in objective response rate or disease control rate were observed among the three groups （ P ＞0.05）. The median progression-free survival was 7.56 （5.62， 8.11） months in group A， 7.23 （5.33， 8.23） months in group B， and 7.33 （5.42， 8.19） months in group C， with no statistically significant difference among the three groups （ P ＞0.05）. The median overall survival （mOS） was 11.67 （8.82， 13.88） months in group A， 9.78 （6.82， 12.73） months in group B， and 9.69 （6.78， 12.66） months in group C. The mOS was significantly longer in group A than in group B and group C （ P ＜0.05）， whereas no statistically significant difference was observed between group B and group C （ P ＞0.05）. The correlation analysis indicated that treatment regimen， Eastern Cooperative Oncology Group performance status （ECOG PS）， number of metastatic organs， and peritoneal metastasis may be associated with overall survival （OS）. No significant association was observed between treatment regimen and the risk of grade 3-4 TRAEs. The incidences of grade 1-2 or grade 3-4 TRAEs did not differ significantly among the three groups （ P ＞0.05）. CONCLUSIONS In patients with advanced gastric adenocarcinoma or AEG with intermediate， low， or no HER2 expression， cadonilimab plus XELOX may provide a more significant OS benefit with a safety profile comparable to that of sintilimab or tislelizumab plus XELOX. Further studies with larger sample sizes are required to validate these findings.

Objective To analyze the technical essentials of single-microport assisted micro-uni-port thoracoscopic surgery, and to investigate its surgical efficacy and promotional value. Methods Clinical data of patients who consecutively underwent radical upper lobectomy in the Department of Thoracic Surgery of Xi'an International Medical Center Hospital from March 2023 to June 2024 were retrospectively analyzed. According to the surgical approach, patients were divided into two groups: the single-microport assisted group (underwent upper lobectomy via single-microport assisted micro-uni-port thoracoscopy) and the traditional uniportal group (underwent traditional uniportal thoracoscopic lobectomy). Clinical outcomes were compared between the two groups. Results A total of 62 patients were enrolled. There were 30 patients in the single-microport assisted group, with a mean age of (57.4±10.8) years, and 32 patients in the traditional uniportal thoracoscopic group, with a mean age of (57.6±8.7) years. The baseline data were comparable between the two groups. All patients in both groups successfully underwent minimally invasive surgery without conversion to thoracotomy. The operative time in the single-microport assisted group was significantly shorter than that in the traditional uniportal group [(146.03±30.79) min vs. (171.41±36.41) min, P=0.004]. However, there were no statistically significant differences between the two groups in intraoperative blood loss, number of dissected lymph nodes, duration of chest tube drainage, postoperative pain score, postoperative hospital stay, hospitalization cost, or incidence of postoperative complications (all P>0.05). Conclusion Single-microport assisted micro-uni-port thoracoscopic surgery for upper lobectomy can maximally integrate the advantages of three-port and uni-port VATS while effectively avoiding their disadvantages. It significantly shortens the operative time without increasing postoperative pain or complications, and represents a more minimally invasive, safer, and more convenient surgical approach.

Objective: To investigate the dynamic influence mechanism of the interaction between physical exercise and pre-sleep screen time on sleep quality among college students, so as to provide a theoretical basis for sleep health interventions in the population. Methods: From March to April 2025, a convenience sample of 2 075 students was recruited from eight universities in Jiangsu Province to participate in an online survey. Physical exercise was assessed using the Physical Activity Rating Scale-3 (PARS-3), sleep quality was evaluated using the Pittsburgh Sleep Quality Index (PSQI), and pre-sleep screen time behaviors were recorded using a self-designed structured questionnaire. Binary Logistic regression was used to examine the independent associations of physical activity level and pre-sleep screen time with sleep disorders. An interaction effect model was then applied to plot the dose-response relationship among the three variables. Results: The overall prevalence of sleep disorder among college students was 50.3%. Significant differences in the prevalence of sleep disorder were observed across groups of sex, academic discipline, grade, pre-sleep screen time, and physical exercise ( χ 2=42.45, 14.81, 18.99, 113.23, 40.61, all P <0.05). Binary Logistic regression showed that pre-sleep screen time was associated with the risk of sleep disorders (≤15 min: OR =1.70; 16- 30 min : OR =1.91; 31-60 min: OR =3.31; >60 min: OR =5.32), while both moderate ( OR =0.44) and high ( OR =0.57) physical exercise were associated with a reduced risk (all P <0.05). The interaction effect was statistically significant (Wald χ 2= 6.82 , P <0.01). The dose-response curves revealed that, in the low-exercise group, sleep quality deteriorated sharply with increasing screen time (the predicted mean dropped to 28% at the >60 min threshold, P <0.01); in the moderate exercise group, an inverted U-shaped trend was observed, with an optimal window of 16-30 min; and in the high exercise group, a significant buffering effect was found, with the predicted mean remaining at 43% even under >60 min screen exposure, representing a decrease of only 4% compared with the no-screen use group ( P >0.05). Conclusions High screen exposure combined with low physical exercise represents the primary behavioral pattern associated with a high prevalence of sleep disorders. Regular physical exercise can partially offset the negative effects of excessive screen time on sleep.

Objective: To evaluate the vaccine effectiveness (VE) of influenza among the elderly aged ≥60 years in Jiaxing City, Zhejiang Province, so as to provide a basis for optimizing influenza vaccination strategies and improving vaccination rates. Methods: A test-negative case-control design was employed. Influenza-like illness cases aged ≥60 years who sought medical care at influenza surveillance sentinel hospitals in Jiaxing City from September 2024 to March 2025 were selected as the study subjects. Influenza virus nucleic acid was detected using real-time fluorescent quantitative reverse transcription polymerase chain reaction (qRT-PCR). Cases with positive nucleic acid tests were included in the influenza virus-positive group, while those with negative tests were included in the influenza virus-negative group. Demographic information, medical history, and influenza vaccination status were collected through questionnaire surveys, medical record information systems, and the Zhejiang Provincial Immunization Program Smart Service Information System. A multivariable logistic regression model was used to analyze the influencing factors for influenza virus positivity and to evaluate VE. Results: A total of 1 145 influenza-like illness cases were included, including 579 males and 566 females, with a male-to-female ratio of 1.02∶1. The age group of 60-<70 years was predominant, accounting for 38.86% (445 cases). A total of 415 cases (36.24%) had received influenza vaccination. There were 393 influenza virus-positive cases (34.32%), all of which were influenza A (H1N1) subtype, and 752 influenza virus-negative cases (65.68%). Multivariable logistic regression analysis revealed that influenza vaccination was associated with a significantly reduced risk of influenza virus positivity (OR=0.538, 95%CI: 0.405-0.716), with a VE of 46.16% (95%CI: 28.38%-59.52%). Subgroup analysis results indicate that influenza vaccination significantly protects older adults regardless of gender, age, underlying medical conditions, or the interval between vaccination and the onset of illness. There is no interaction between gender, age, underlying medical conditions, the interval between vaccination and onset of illness, and the influenza vaccination on influenza virus positivity (Pfor interaction>0.05). Conclusions Influenza vaccines provide protective effects against influenza A (H1N1) virus infection among the elderly in Jiaxing. It is recommended to continue promoting influenza vaccination among the elderly.

Objective: To analyze the epidemic periods and excess cases of hand, foot and mouth disease (HFMD) in Jiaxing City, Zhejiang Province from 2015 to 2024, so as to provide evidence for optimizing prevention and control strategies for HFMD. Methods: Data on HFMD cases in Jiaxing City from 2015 to 2024 were collected through the Infectious Disease Reporting Information System of China Disease Prevention and Control Information System. Descriptive analyze demographic and temporal distributions of HFMD. The adjusted Serfling regression model was constructed based on the weekly number of HFMD cases reported in Jiaxing City from 2015 to 2024 to estimate the baseline and epidemic threshold of HFMD incidence. An epidemic period was defined as a period during which the actual number of cases exceeded the epidemic threshold for more than 2 consecutive weeks, with an interval of no more than 1 week between epidemic periods. Excess cases were defined as the difference between the reported number of cases and the baseline number of cases during the epidemic periods. Results: A total of 91 859 HFMD cases were reported in Jiaxing City from 2015 to 2024, with an average annual reported incidence of 183.90/105. There were 54 064 male cases (58.86%) and 37 795 female cases (41.14%). The majority of cases were aged 0-<5 years and scattered-living children, with 71 505 cases (77.84%) and 47 387 cases (51.59%). The temporal distribution of HFMD presented a bimodal pattern, with two peaks from May to July and September to November, with 44 578 cases (48.53%) and 23 434 cases (25.51%), respectively. After excluding data of 2017 (promotional vaccination of inactivated enterovirus 71 vaccine) and 2020-2022 (COVID-19 prevention and control), the adjusted Serfling regression model achieved good fitting performance (R2=0.740). Six epidemic periods were identified from 2015 to 2024, including June 2016, May to July and September to October 2018, June to August and September to October 2023, and June to July 2024, with a cumulative epidemic duration of 28 weeks, and 16 772 excess cases accumulated in these periods. Conclusions HFMD in Jiaxing City showed a bimodal temporal distribution from 2015 to 2024, with high incidence among children aged 0-<5 years and scattered-living children. Six epidemic periods were identified by the adjusted Serfling regression model. Early warning should be strengthened for spring and summer peaks and high-risk populations.

It is believed that diabetes complicated with coronary heart disease is closely related to the functional interplay of the heart， spleen， and kidneys. This paper proposed the concept of the heart-spleen-kidney as a unified system for understanding and treating the disease. At the early stage， spleen and kidney deficiency leads to the internal accumulation of phlegm， dampness， and turbid lipids， causing impaired blood circulation and vascular obstruction， so treatment should focus on tonify the kidneys and strengthening the spleen， activating blood circulation and resolving stasis， using the self-prescribed Tangxin Maiwen Formula （糖心脉温方）. As the disease progresses， further decline of spleen and kidney function results in inadequate nourishment of the heart， leading to blood stasis and the accumulation of phlegm， dampness， and turbid lipids， which may transform into pathogenic heat and toxins， causing heart damage， then treatment should emphasize on boosting qi and nourishing yin， clearing heat， activating blood and resolving toxins， using the self-prescribed Tangxin Maiqing Formula （糖心脉清方）. In advanced stages， three zang organs， the heart， spleen， and kidneys， become severely impaired， leading to mental activity fail to be nourished and abnormal cognitive functions， so treatment should focus on harmonizing the three zang organs simultaneously， using the self-prescribed Yunpi Tiaoxin Decoction （运脾调心汤）. This approach aims to provide a clinical framework for the diagnosis and treatment of diabetes with coronary heart disease.

This article summarized clinical experience in differentiating and treating non-obstructive hypertrophic cardiomyopathy （HCM） based on the concept of nourishing the heart and softening the hardness. It is considered that HCM belongs to the category of "heart accumulation"， with the fundamental cause being depletion of the spleen and kidney， and phlegm-stasis accumulation， as well as qi-yin exhaustion， serving as the manifestations. Spleen and kidney depletion leads to the transformation of phlegm and stasis， which accumulate in the heart； over time， this phlegm-stasis accumulation consumes heart qi and yin， resulting in the heart being deprived of nourishment， which eventually leads to the damage to both the function and structure of heart. Therefore， the method of nourishing the heart and softening the hardness is proposed for the treatment of non-obstructive HCM. Emphasis is placed on softening hardness and dissipating masses throughout the entire treatment process， often using Modified Siwei Ruanjian Formula （四味软坚方加减）. During periods with prominent symptoms， the main treatment is boosting qi and nourishing yin to soften hardness and dissipate masses with self-made Yuxin Ruanjian Formula （自拟育心软坚方） in modifications； in stable periods， the main treatment is boosting kidney and fortifying spleen to soften hardness and dissipate masses with self-made Pishen Tongzhi Formula （脾肾同治方） in modifications.

ObjectiveTo investigate the change in the activity of hepatitis B virus （HBV）-specific CD8⁺ T cells after pegylated interferon-α-2b （PEG-IFN-α-2b） therapy in HBeAg-negative patients with chronic HBV infection. MethodsA total of 53 HBeAg-negative patients with chronic HBV infection who attended The First Affiliated Hospital of Xinxiang Medical University and Tangdu Hospital of Air Force Mdical University from April 2020 to June 2022 were enrolled and treated with PEG-IFN-α-2b （180 μg/week， subcutaneous injection） antiviral therapy. The study endpoint was HBsAg clearance （course of treatment<48 weeks） or 48 weeks （course of treatment≥48 weeks）. Peripheral blood mononuclear cells were isolated at baseline and study endpoint， and peripheral blood T cell counts were measured. Enzyme-linked immunospot assay was used to measure the frequency of HBV-specific CD8⁺ T cells secreting perforin， granzyme B， and interferon-γ. A total of 17 HLA-A^*02-restricted patients were selected， and CD8⁺ T cells were purified to establish direct- and indirect-contact co-culture systems for HBV-specific CD8⁺ T cells and HepG2.2.15 cells. The level of lactate dehydrogenase in supernatant was measured to calculate the mortality rate of HepG2.2.15 cells， and the levels of HBV DNA， cytotoxic molecules， and cytokines in supernatant were also measured. Flow cytometry was used to measure the expression of apoptosis ligands， and the cytotoxicity of HBV-specific CD8⁺ T cells was evaluated. The independent samples t-test or the paired t-test was used for comparison of normally distributed continuous data between two groups， and the Mann-Whitney U test or the Wilcoxon rank-sum test was used for comparison of non-normally distributed continuous data between two groups. ResultsThe HBsAg clearance rate at study endpoint was 30.19% （16/53）. There were no significant differences in peripheral blood T cell counts （CD3⁺， CD4⁺， and CD8⁺ T cells） between baseline and study endpoint （P>0.05）. At study endpoint， there was a significant increase in the frequency of HBV-specific CD8⁺ T cells secreting perforin， granzyme B， and interferon-γ （U=177.50， t=11.90， U=186.50， all P<0.001）， and the patients with HBsAg clearance had a significantly higher frequency of such HBV-specific CD8⁺ T cells than those without HBsAg clearance （U=120.50， t=2.73， U=121.50， all P<0.01）. In the direct- and indirect-contact co-culture systems at study endpoint， HBV-specific CD8⁺ T cells induced a significant reduction in HBV DNA in the supernatant of HepG2.2.15 cells （all P<0.001） and significant increases in the secretion of interferon-γ and tumor necrosis factor-α （all P<0.05）； in the direct-contact co-culture system， HBV-specific CD8⁺ T cells induced significant increases in the mortality rate of HepG2.2.15 cells （13.62%±3.27% vs 11.39%±2.40%， t=2.27， P=0.030） and the secretion of perforin and granzyme B （t=72.50， U=52.50， both P<0.05）. In the direct- and indirect-contact co-culture systems， compared with HBV-specific CD8⁺ T cells from the patients without HBsAg clearance， the HBV-specific CD8⁺ T cells from patients with HBsAg clearance had a significantly greater reduction in HBV DNA （P<0.05） and significant increases in the secretion of interferon-γ and tumor necrosis factor-α （P<0.05）. ConclusionPEG-IFN-‍α‍-2b therapy can help to achieve a relatively high HBsAg clearance rate in HBeAg-negative patients with chronic HBV infection， and the activity of HBV-specific CD8⁺ T cells is significantly enhanced， which is closely associated with HBsAg clearance.